COMMUNIQUÉS West-GlobeNewswire

Shire plc : Rule 2.9 Announcement

21/05/2018 - 08:01

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 21 May 2018 Shire [...]

PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")

21/05/2018 - 07:01

REGULATED INFORMATION GHENT, Belgium, 21 May 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]

GLPG1690 results in IPF published in The Lancet Respiratory Medicine and presented at ATS

20/05/2018 - 20:31

Mechelen, Belgium; 20 May 2018; 20.30 CET; Galapagos NV (Euronext & NASDAQ: GLPG) announces publication milestones on GLPG1690 in idiopathic pulmonary fibrosis (IPF). In addition to presenting three abstracts on [...]

Solid Biosciences Announces New Preclinical Data at the American Society of Gene and Cell Therapy Annual Meeting

19/05/2018 - 00:45

- Data Reinforce Potential of SGT-001 as an Important Treatment Candidate for DMD - - Company Continues to Advance Gene Therapy Portfolio - CAMBRIDGE, Mass., May 18, 2018 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. ( [...]

Voyager Therapeutics Announces Additional Data at the American Society of Gene and Cell Therapy 2018 Annual Meeting

19/05/2018 - 00:30

Voyager’s gene therapy vector for Friedreich’s ataxia prevents central and peripheral disease progression in preclinical model out to one year after a single administration Durable safety data generated with Voyager’s [...]

BK Ultrasound, Powered by Analogic, Launches bkSpecto Ultrasound System for Urology at the 2018 American Urological Association Annual Meeting

18/05/2018 - 23:19

PEABODY, Mass., May 18, 2018 (GLOBE NEWSWIRE) -- Analogic Corporation (Nasdaq: ALOG ), enabling the world’s medical imaging and aviation security technology, today announced that it will launch the bkSpecto™ ultrasound [...]

Editas Medicine Reports Data Demonstrating Subretinal Injection of EDIT-101 Well-tolerated in Non-human Primates

18/05/2018 - 23:00

Presentation at the Annual Meeting of the American Society of Gene & Cell Therapy CAMBRIDGE, Mass., May 18, 2018 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ: EDIT ), a leading genome editing company, today [...]

National Brain Tumor Society Brings Realities of Glioblastoma to Congress

18/05/2018 - 22:57

National Brain Tumor Society and Senator Lindsey Graham Host Briefing on Glioblastoma to Educate Congressional Offices on Tumor Type Affecting Their Colleague, Senator John McCain Washington, D.C., May 18, 2018 (GLOBE [...]

Affimed Announces Annual General Meeting of Shareholders

18/05/2018 - 22:01

Heidelberg, Germany, May 18, 2018 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, announced today that the Annual [...]

Tower One Wireless Completes Acquisition of Mexico Tower Company With AT&T Master Lease Agreement

18/05/2018 - 20:30

VANCOUVER, British Columbia, May 18, 2018 (GLOBE NEWSWIRE) -- Tower One Wireless Corp (CSE:TO) (OTCQB:TOWTF) (Frankfurt: 1P3N ) (“Tower One” or the “Company”) is pleased to announce that further to its news release [...]

NAPA Ranks Tops on Becker’s and Black Book Best Lists

18/05/2018 - 20:15

MELVILLE, N.Y., May 18, 2018 (GLOBE NEWSWIRE) -- North American Partners in Anesthesia (NAPA) , one of the leading single-specialty anesthesia and perioperative management companies in the US, is pleased to announce it [...]

Adherium’s Technology Used for Large Scale Electronic Data Capture in Landmark Mild-Asthma Trials

18/05/2018 - 20:04

SAN MATEO, Calif., May 18, 2018 (GLOBE NEWSWIRE) -- Adherium (ASX:ADR), a digital health company that improves medication adherence and patient outcomes, announced the extensive use of it’s Hailie ™ (previously known as [...]

Cesca Announces Closing of $5.5 Million Public Offering

18/05/2018 - 17:12

RANCHO CORDOVA, Calif., May 18, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ: KOOL ), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced the [...]

Medtronic Announces 2018 Institutional Investor and Analyst Meeting and Webcast

18/05/2018 - 17:01

DUBLIN - May 18, 2018 - Medtronic plc (NYSE: MDT ) announced today that the company will host its biennial Institutional Investor and Analyst Meeting on Tuesday, June 5, 2018, in New York City from 8:00 a.m. to [...]

Avadel to Present Late-Breaker Data and Product Theater Forum at the 2018 American Urological Association Annual Meeting

18/05/2018 - 17:00

Data demonstrates extended first uninterrupted sleep period in elderly patients Key opinion leaders to present “NOCTIVA™: Addressing a Nighttime Condition with Daytime Consequences” DUBLIN, Ireland, May 18, 2018 (GLOBE [...]

Saniona regains full rights to BenevolentAI program

18/05/2018 - 16:45

PRESS RELEASE May 18, 2018 Saniona, a leading biotech company within ion-channel research, today announces that BenevolentAI and Saniona will terminate the collaboration program in neurology. Saniona regains all rights [...]

Orion Corporation: Managers' transactions - Karvonen Eero kuolinpesä

18/05/2018 - 16:16

ORION CORPORATION MANAGERS' TRANSACTIONS 18 MAY 2018 at 17.15 EETS Orion Corporation: Managers' transactions - Karvonen Eero kuolinpesä Orion Corporation has received the following disclosure under Market Abuse [...]

Gemphire Therapeutics Provides the American Liver Foundation an Educational Grant in Support of Disease State Awareness for Pediatric NAFLD

18/05/2018 - 15:29

Webinar on Wednesday, May 23, at 8:00am Eastern Time LIVONIA, Mich., May 18, 2018 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ: GEMP ), a clinical-stage biopharmaceutical company focused on developing and [...]

Abeona Therapeutics Provides Clinical Update on MPS IIIA Gene Therapy Trial at the 21st Annual ASGCT Meeting

18/05/2018 - 15:25

ABO-102 18-month efficacy and safety data continue to demonstrate time- and dose-dependent reductions in underlying disease pathology, including decreased CSF and urine GAGs and improved liver volumes 11 subjects [...]